By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues for the third quarter grew 13 percent to $2.97 billion, but lowered its revenue and EPS estimates for full-year 2011 reflecting weakness in the academic/government market.

Revenues for the three months ended Oct. 1 compare to $2.63 billion from the year ago period and missed analyst estimates of $3 billion for the quarter.

Organically, revenues grew 3 percent year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.